Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-08 Sale |
2020-12-10 4:16 pm |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $33.78 | $101,327 | 221,171 (Direct) |
View |
| 2020-12-03 Sale |
2020-12-04 4:34 pm |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $32.42 | $81,055 | 179,309 (Direct) |
View |
| 2020-12-01 Sale |
2020-12-03 4:17 pm |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
12,000 | $32.71 | $392,574 | 1,203,685 (Indirect Direct) |
View |
| 2020-11-30 Sale |
2020-12-01 7:13 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
10,393 | $33.15 | $344,513 | 2,138,983 (Indirect Direct) |
View |
| 2020-11-30 Sale |
2020-12-01 7:13 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
10,393 | $33.15 | $344,513 | 6,062,813 (Indirect Direct) |
View |
| 2020-11-19 Sale |
2020-11-23 4:41 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
130,017 | $33.01 | $4,291,861 | 7,646,829 (Indirect Direct) |
View |
| 2020-11-19 Sale |
2020-11-23 4:39 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
130,017 | $33.01 | $4,291,861 | 6,693,509 (Indirect Direct) |
View |
| 2020-11-17 Sale |
2020-11-19 9:19 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
4,730 | $33.05 | $156,349 | 6,808,363 (Indirect Direct) |
View |
| 2020-11-17 Sale |
2020-11-19 9:19 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
4,730 | $33.05 | $156,349 | 7,776,846 (Indirect Direct) |
View |
| 2020-11-13 Sale |
2020-11-17 7:33 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
4,700 | $33.74 | $158,587 | 7,781,576 (Indirect Direct) |
View |
| 2020-11-13 Sale |
2020-11-17 7:28 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
4,700 | $33.74 | $158,587 | 6,812,541 (Indirect Direct) |
View |
| 2020-11-12 Sale |
2020-11-13 7:47 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
15,598 | $34.15 | $532,642 | 6,937,033 (Indirect Direct) |
View |
| 2020-11-12 Sale |
2020-11-13 7:46 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
15,598 | $34.15 | $532,642 | 5,972,906 (Indirect Direct) |
View |
| 2020-11-11 Sale |
2020-11-13 4:26 pm |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
5,000 | $34.9 | $174,500 | 181,809 (Direct) |
View |
| 2020-11-12 Sale |
2020-11-13 4:25 pm |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $33.99 | $138,607 | 193,342 (Direct) |
View |
| 2020-11-10 Sale |
2020-11-12 5:41 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
39,583 | $34.11 | $1,350,354 | 8,751,874 (Indirect Direct) |
View |
| 2020-11-10 Sale |
2020-11-12 5:38 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
39,583 | $34.11 | $1,350,354 | 7,775,016 (Indirect Direct) |
View |
| 2020-11-09 Sale |
2020-11-12 5:00 pm |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $32.96 | $98,892 | 224,171 (Direct) |
View |
| 2020-11-06 Sale |
2020-11-10 7:24 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
9,400 | $33.08 | $310,949 | 8,791,457 (Indirect Direct) |
View |
| 2020-11-06 Sale |
2020-11-10 7:24 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
9,400 | $33.08 | $310,949 | 7,809,983 (Indirect Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 4:49 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
11,348 | $33.14 | $376,127 | 7,818,286 (Indirect Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 4:44 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
11,348 | $33.14 | $376,127 | 8,800,857 (Indirect Direct) |
View |
| 2020-11-03 Sale |
2020-11-04 8:37 pm |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $31.95 | $79,873 | 186,809 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-03 7:56 pm |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
12,000 | $31.14 | $373,656 | 1,215,685 (Indirect Direct) |
View |
| 2020-10-26 Sale |
2020-10-28 5:58 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
8,903 | $33.28 | $296,293 | 8,812,205 (Indirect Direct) |
View |
| 2020-10-26 Sale |
2020-10-28 5:51 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
8,903 | $33.28 | $296,293 | 7,828,310 (Indirect Direct) |
View |
| 2020-10-15 Sale |
2020-10-20 8:09 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
15,746 | $33.44 | $526,529 | 8,821,108 (Indirect Direct) |
View |
| 2020-10-15 Sale |
2020-10-20 8:03 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
15,746 | $33.44 | $526,529 | 7,836,175 (Indirect Direct) |
View |
| 2020-10-13 Sale |
2020-10-15 7:26 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
17,240 | $33.3 | $574,015 | 7,850,084 (Indirect Direct) |
View |
| 2020-10-13 Sale |
2020-10-15 7:22 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
17,240 | $33.3 | $574,015 | 8,836,854 (Indirect Direct) |
View |
| 2020-10-12 Sale |
2020-10-14 4:32 pm |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $32.7 | $133,331 | 197,420 (Direct) |
View |
| 2020-10-08 Sale |
2020-10-13 7:48 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
22,625 | $33.5 | $757,924 | 7,865,313 (Indirect Direct) |
View |
| 2020-10-08 Sale |
2020-10-13 7:41 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
22,625 | $33.5 | $757,924 | 8,854,094 (Indirect Direct) |
View |
| 2020-10-08 Sale |
2020-10-09 4:12 pm |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $33.53 | $100,576 | 227,171 (Direct) |
View |
| 2020-10-06 Sale |
2020-10-08 7:14 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
45,926 | $33.44 | $1,535,732 | 311,881 (Indirect Direct) |
View |
| 2020-10-06 Sale |
2020-10-08 7:14 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
45,926 | $33.44 | $1,535,732 | 6,056,892 (Indirect Direct) |
View |
| 2020-10-05 Sale |
2020-10-07 4:27 pm |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $31.28 | $78,188 | 189,309 (Direct) |
View |
| 2020-10-01 Sale |
2020-10-02 5:07 pm |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
12,000 | $30.33 | $363,962 | 1,227,685 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-08 Exercise |
2020-12-10 4:16 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $10.86 | 221,171 (Direct) |
View |
| 2020-12-08 Exercise |
2020-12-10 4:16 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $0 | 221,171 (Direct) |
View |
| 2020-12-03 Exercise |
2020-12-04 4:34 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $10.86 | 179,309 (Direct) |
View |
| 2020-12-03 Exercise |
2020-12-04 4:34 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $0 | 179,309 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 4:17 pm |
N/A 2029-08-13 |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
3,000 | $0 | 1,203,685 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 4:17 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
3,000 | $6.42 | 1,203,685 (Direct) |
View |
| 2020-11-27 Other |
2020-12-01 7:13 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
443,053 | $0 | 2,138,983 (Indirect) |
View |
| 2020-11-27 Other |
2020-12-01 7:13 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
440,782 | $0 | 6,062,813 (Direct) |
View |
| 2020-11-23 Other |
2020-11-25 4:49 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
788,828 | $0 | 5,151,052 (Direct) |
View |
| 2020-11-23 Other |
2020-11-25 4:45 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
792,763 | $0 | 832,615 (Indirect) |
View |
| 2020-11-11 Other |
2020-11-13 7:47 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
984,298 | $0 | 6,937,033 (Direct) |
View |
| 2020-11-11 Other |
2020-11-13 7:46 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
989,754 | $0 | 5,972,906 (Indirect) |
View |
| 2020-11-11 Exercise |
2020-11-13 4:26 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
5,000 | $10.86 | 181,809 (Direct) |
View |
| 2020-11-11 Exercise |
2020-11-13 4:26 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
5,000 | $0 | 181,809 (Direct) |
View |
| 2020-11-12 Exercise |
2020-11-13 4:25 pm |
N/A 2029-06-11 |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $0 | 193,342 (Direct) |
View |
| 2020-11-12 Exercise |
2020-11-13 4:25 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $3.2 | 193,342 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 5:00 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $10.86 | 224,171 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 5:00 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $0 | 224,171 (Direct) |
View |
| 2020-11-03 Exercise |
2020-11-04 8:37 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $10.86 | 186,809 (Direct) |
View |
| 2020-11-03 Exercise |
2020-11-04 8:37 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $0 | 186,809 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-03 7:56 pm |
N/A 2029-08-13 |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
3,000 | $0 | 1,215,685 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-03 7:56 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
3,000 | $6.42 | 1,215,685 (Direct) |
View |
| 2020-10-12 Exercise |
2020-10-14 4:32 pm |
N/A 2029-06-11 |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $0 | 197,420 (Direct) |
View |
| 2020-10-12 Exercise |
2020-10-14 4:32 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $3.2 | 197,420 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-09 4:12 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $10.86 | 227,171 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-09 4:12 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $0 | 227,171 (Direct) |
View |
| 2020-10-07 Other |
2020-10-08 7:14 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
300,522 | $0 | 311,881 (Indirect) |
View |
| 2020-10-07 Other |
2020-10-08 7:14 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
299,051 | $0 | 6,056,892 (Indirect) |
View |
| 2020-10-05 Exercise |
2020-10-07 4:27 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $10.86 | 189,309 (Direct) |
View |
| 2020-10-05 Exercise |
2020-10-07 4:27 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $0 | 189,309 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-02 5:07 pm |
N/A 2029-08-13 |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
3,000 | $0 | 1,227,685 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-02 5:07 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
3,000 | $6.42 | 1,227,685 (Direct) |
View |